在商业保险个人中,暴露前预防药物遵守的轨迹
Ikenna Unigwe1, Amie Goodin1, Wei-Hsuan Lo-Ciganic2,3,4
1Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
概括
只有44.5%的暴露前预防 (PrEP) 用户表现出一致的坚持. 年龄较小,女性性别,物质使用障碍和抑郁症与早期停药有关,强调需要改进公共卫生战略.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 行为科学 行为科学
背景情况:
- 暴露前预防 (PrEP) 是一种重要的生物医学艾滋病毒预防策略.
- 了解坚持模式对于优化PrEP有效性至关重要.
- 识别与PrEP不遵守相关的因素可以告知有针对性的干预措施.
研究的目的:
- 在大量的使用者群体中确定暴露前预防 (PrEP) 的不同坚持轨迹.
- 确定与早期停止PrEP相关的人口和临床因素.
主要方法:
- 基于组的轨迹建模被用来分析坚持模式.
- 分析了20696名PrEP用户的数据,以确定不同的坚持轨迹.
- 统计分析确定了与早期PrEP停药相关的因素.
主要成果:
- 确定了四种不同的PrEP坚持轨迹模式.
- 只有44.5%的用户观察到一致的遵守.
- 年龄较小,女性性别,物质使用障碍和抑郁症与早期 PrEP 停用有显著联系.
结论:
- 很大一部分PrEP使用者没有保持一致的坚持.
- 特定人群,包括年轻人,女性,以及那些有物质使用障碍或抑郁症的人,需要量身定制的支持.
- 加强公共卫生倡议是必要的,以改善PrEP的持续遵守,并最大限度地提高艾滋病毒预防工作.
相关概念视频
Factors Influencing Drug Absorption: Presystemic Elimination
225
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
225
Non-Oral Extravascular Drug Absorption Routes
218
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
218
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Bioavailability: Overview
2.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.8K


